Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Mammalian transporters are a vast class of membrane proteins that facilitate the movement of ions, nutrients, and xenobiotics across biological membranes (UniProt, 2024). They are broadly divided into the Solute Carrier (SLC) superfamily, which includes over 400 members, and the ATP-Binding Cassette (ABC) superfamily (Hediger et al., 2013). These proteins are essential for maintaining cellular homeostasis, regulating pH, and managing the uptake of vital substances like glucose and amino acids (NIH, 2023). In the context of pharmacology, transporters are critical components of the ADME (Absorption, Distribution, Metabolism, and Excretion) profile of drugs, often determining the bioavailability and tissue distribution of therapeutic agents (Giacomini et al., 2010). Many transporters are direct therapeutic targets, such as the serotonin transporter (SERT) for antidepressants or the sodium-glucose cotransporter 2 (SGLT2) for diabetes (PubMed, 2023). However, they are also frequent sites of drug-drug interactions, where one drug inhibits the transport of another, leading to potential toxicity (FDA, 2020). Genetic polymorphisms in transporter genes can significantly impact individual drug responses and disease susceptibility (StatPearls, 2024).
Inhibition of substrate translocation, competitive inhibition at the binding site, non-competitive or allosteric modulation of transport activity, and induction or repression of transporter expression (Giacomini et al., 2010; PubMed, 2023).
6 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Mammalian transporter.